INTRODUCTION
Glutamate is the major excitatory transmitter at both the crustacean and insect neuromuscular junctions (Takeuchi, 1987; Usherwood, 1978) . In the vertebrate central nervous system three different types of glutamate receptor coupled to cation channels have been identified, on the basis of their relative affinities for three specific agonists (Watkins & Evans, 1981) . The three agonists now used to define these receptors are N-methyl-D-aspartate, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and kainate. In addition, a G-protein-linked receptor, named the metabotropic receptor, has recently been described (Sugiyama et al., 1989) . The pharmacology of the crustacean neuromuscular-junction glutamate receptor is similar to that of the vertebrate AMPA receptor, since quisqualate is a potent depolarizing agent in crustacean muscle (Shinozaki & Shibuya, 1974) , as well as being active at the vertebrate AMPA receptor. By contrast, N-methyl-D-aspartate has no effect (McBain & Wheal, 1984) , and kainate acts at an extra junctional receptor which is present on the muscle plasma membrane (Shinozaki, 1980) . Despite extensive studies on the pharmacology and electrophysiology of the glutamate receptors in both vertebrates and invertebrates (Fonnum, 1984; Takeuchi, 1987) , relatively little biochemical or structural information was known until recently. The solubilization and isolation of the kainate receptor from chicken brain (Gregor et al., 1988) and frog brain (Hampson & Wenthold, 1988 ) and a glutamate-binding protein from rat brain (Kuonen & Roberts, 1987; Chen et al., 1988) have all now been reported. In addition the DNAs encoding two kainate-binding proteins (of approx. Mr 52000) have been cloned and sequenced (Wada et al., 1989; Gregor et al., 1989) , and a rat kainate-sensitive-receptor DNA that specifies a protein of Mr 99 800 has been functionally expressed (Hollman et al., 1989 ).
This in turn has led to the isolation of three more glutamate receptor DNAs, which code for AMPA-sensitive receptors in rat brain (Keinanen et al., 1990) .
We considered it likely that crustacean muscle would be a rich source of the quisqualate-sensitive receptor, which could be isolated in the absence of the other excitatory amino acid receptors. We report here the characterization, solubilization and purification of a quisqualate-sensitive glutamate-binding protein from crustacean muscle.
EXPERIMENTAL

Materials
All standard laboratory chemicals were obtained from either Sigma or BDH (both of Poole, Dorset, U.K. 
Preparation of crude muscle membranes
Approx. 50 g of Nephrops abdominal muscle was finely chopped and homogenized in 0.4 M-sucrose/0.4 M-glycine, pH 7.4, containing 1 mM-EDTA, 1 mM-phenylmethanesulphonyl fluoride (PMSF) and 1 mM-benzamidine in a rotating (640 rev./min) glass/Teflon homogenizer at 4 'C. After centrifugation at 1000 g for 10 min to remove cell debris, the supernatant was re-centrifuged at 15000 g for 45 min. The resultant pellet was then hypo-osmotically lysed with 240 ml of 1 mm-EDTA/1 mM-PMSF/1 mM-benzamidine and re-homogenized.
After re-centrifugation at 48000 g for 10 min, the membrane Vol. 273
Abbreviations used: PMSF, phenylmethanesulphonyl fluoride; AMPA, ac-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; IC50, concn. giving 50 % inhibition.
pellet was washed four times by resuspension with 50 mM-Tris acetate buffer, pH 7.4, containing 1 mM-EDTA, 1 mM-PMSF and 1 mM-benzamidine, with centrifuging between washes. The final membrane pellet (P2) was resuspended in 20 ml of 50 mMTris acetate (protein concn. approx. 0.6 mg/ml) and used in the membrane-binding assays.
Solubilization and purification of glutamate-binding proteins Solubilization conditions were optimized by addition of various detergents to the muscle membranes and stirring slowly for 1 h at 4 'C. Routinely this involved the addition of (final concns.) sodium cholate (0.25%, w/v), NaCl (1.5 M), PMSF (1 mM), EDTA (1 mM), benzamidine (1 mM), pepstatin A (10 mM), E-64 (20 mM), leupeptin (20 mM), N-tosyl-L-phenylalanylchloromethane (100 mM) and N-p-tosyl-L-lysylchloromethane (10 mM).
The solubilized membranes were subsequently centrifuged at 100000 g for 1 h, and the supernatant was then recirculated for 16 h at 4 'C through a 4 ml column ofconcanavalin A-Sepharose. Samples of the solubilized membranes were kept for assay and dialysed for 16 h against 2 litres of buffer A (10 mM-Tris adjusted to pH 7.4 with acetic acid, 0.5 M-NaCl, 1 mM-CaCI2, 1 mMMgCl2, 0.05 0/% cholate, 1 mM-EDTA, 1 mM,-PMSF, 1 mM-benzamidine).
The concanavalin A-Sepharose column was drained, washed with 200 ml of Buffer A, and the bound proteins were eluted with 5 x 4 ml of Buffer A containing 0.5 M-a-methyl mannoside. The first three eluates were pooled and dialysed for 3 h against 3 litres of 50 mM-NaCl/ I0 mM-Tris acetate (pH 7.4)/I mM-CaCl2/1 mMMgCl2/0.05 % cholate/ 1 mM-EDTA/I mM-PMSF/I mM-benzamidine. The dialysed sample was concentrated to 0.8 ml under vacuum (without freezing) and loaded on a 50 cm x 0.9 cm AcA34 column equilibrated with Buffer A. The column was run at 3.0 ml/h at 4 'C, and 1 ml fractions were collected. The column was calibrated with the following marker proteins: urease, alcohol dehydrogenase, bovine serum albumin and carbonic anhydrase. Blue Dextran was used to measure the void volume and N-acetyltyrosine the total column volume.
Glutamate-binding assays
Glutamate binding to muscle membranes was based on the method of Sharif & Roberts (1984) . Samples (0.225 ml) of membranes were incubated with 0.025 ml of competing ligand or 50 mM-Tris acetate, pH 7.4, for 30 min at 20 'C. Then 0.025 ml of [3H]glutamate (25 nm final concn.) was added and the incubation continued for a further 30 min. The reaction was terminated by centrifugation for 5 min in an MSE Microcentaur (8000 rev./min) and the supernatant removed by aspiration. Pellets were superficially washed twice with ice cold Tris acetate buffer and then counted for radioactivity by liquidscintillation counting. Displacement curves for various ligands were carried out by preincubating the membranes with a range of ligand concentrations (1 mM-1 nM) before addition of the labelled glutamate.
Glutamate binding to solubilized proteins was measured by preincubation for 30 min at 20 'C of 0.1 ml or 0.2 ml samples, with or without 0.025 ml of competing ligand, in a total volume of 0.25 ml, in 50 mM-Tris acetate, pH 7.4. After addition of 0.025 ml of [3H]glutamate (25 nm final concn.) and a further incubation for 30min at 20 'C, the soluble proteins were precipitated by addition of 0.5 ml of bovine y-globulins (1.5 mg/ml) in 0.1 M-phosphate buffer (pH 7.4) followed by 0.5 ml of ice-cold poly(ethylene glycol) (25 %, w/v), and centrifuged at 2000g for10 min: After a rinse with 0.5-ml-of 9% poly(ethylene glycol) the pellets were re-centrifuged, and subjected to liquid-scintillation counting; Nen-specific (Monaghan et al., 1984) , was a poor ligand in this system. Fig.  4 , where it is apparent that few of the major solubilized proteins were specifically eluted from this column by a-methyl mannoside, except for a polypeptide of Mr 74000. The first 12 ml of a-methyl mannoside eluate containing the glutamate-binding activity was then subjected to gel filtration. Three peaks of glutamate-binding activity were observed (Fig. 3) . The first, which was eluted with an apparent Stokes radius of 5.4 nm, was detected in every Table 1 . Detergent solubilization of crustacean muscle membranes Membranes were isolated from Nephrops abdominal muscle as described in the Experimental section. The membranes were solubilized by gentle stirring for 1 h at 4°C, in the above detergents, centrifuged at 100000 g for 1 h, and the solubilized supernatant was dialysed overnight against 5 x 11 batches of Buffer A. The dialysed supernatant was assayed as described in the Experimental section. Results are expressed as percentages of the total activity initially present in P2 (mean + range) (n = 2). 
Fig. 3. Gel-filtration chromatography
The concanavalin A-Sepharose column eluate was submitted to gel filtration on an AcA34 column as described in the Experimental section: 1 ml fractions were collected and assayed for glutamatebinding activity. Fig. 3 . Electrophoresis was carried out under reducing conditions as described in the Experimental section. experiment and consisted of one major polypeptide of Mr 74000 as observed by SDS/polyacrylamide-gel electrophoresis (Fig. 4) . A variable amount of glutamate-binding activity was eluted near the middle of the column run and consisted of two major polypeptides (Fig. 4) . The size of this peak was greatly enhanced, at the expense of the first peak, if the protease inhibitors were omitted from the solubilization buffer (results not shown). A third peak of glutamate-binding protein was eluted with Nacetyltyrosine at the end of the column run. SDS/polyacrylamide-gel electrophoresis revealed a polypeptide of Mr 65000 (Fig. 4) . This polypeptide had presumably bound loosely to the column matrix and so was eluted anomalously. (-) . The non-specific binding component, i.e. that in the presence of 1 mM-glutamate, amounted to 50 % of the total binding. of 1.3 + 0.1 1aM andaBmax of 14.5 + 3.1 nmol/mg. If it is assumed that the molecular mass of the Mr-74000 protein in nondenaturing conditions is approx. 300 kDa [i.e. between that of urease and the exclusion limit (350 kDa) of the gel-filtration matrix], then the Bmax of this protein is consistent with 4.6 mol of glutamate binding/mol of protein, whereas the Bmax of the Mr-65000 polypeptide implies the binding of 0.9 mol of glutamate/mol of protein. The sensitivity of these glutamatebinding proteins to quisqualate and kainate was also examined. As shown in Fig. 6 , the protein of Mr 74000 was sensitive to quisqualate (IC50 for glutamate binding was 1 I4M) but not to kainate, whereas the Mr-65 000 was sensitive to neither analogue.
DISCUSSION
Central-nervous-system glutamate receptors are currently the focus of considerable attention, since they have been implicated in processes such as long-term potentiation (Collingridge et al., 1983) and ischaemic damage (Onodera et al., 1986) (1988) were unable to assign an approximate molecular size to the intact receptor, owing to the interaction of the gel-filtration matrices with these polypeptides. We chose to attempt the purification of the crustacean receptor for a number of reasons: (1) the dense innervation (Florey & Cahill, 1982) suggested the presence of large numbers of receptor molecules; (2) the receptor is predominantly of one type; (3) tissue is available in relatively large quantities; and (4) it was known that concanavalin A interacted with the receptor (Mathers & Usherwood, 1976 , 1978 Shinozaki & Ishida, 1979) .
The preliminary characterization of the glutamate receptor in the muscle membrane as reported here is consistent with the presence of a quisqualate-sensitive receptor. The rank order of potency observed in this preparation, i.e. glutamate > quisqualate > ibotenate > kainate, is similar to that observed when the post-synaptic action of these agonists is measured electrophysiologically in crustacean muscle. In such analyses quisqualate is more potent than glutamate, perhaps because it is not metabolized by the tissue, whereas ibotenate and kainate have relatively little effect (Shinozaki, 1980) . Similarly, the ability of domoate to modulate depolarization of crayfish muscle is much greater than that of kainate (Shinozaki, 1988) . This is reflected in the greater ability of domoate to displace glutamate in this preparation, i.e. the IC20 (concn. giving 20% inhibition) for domoate was 0.1 IuM and the IC20 for kainate was 1 /LM. Interestingly, the ibotenate-induced hyperpolarization of crayfish muscle has a half-maximal effect at 0.2 mm (Shinozaki & Ishida, 1980) , whereas its IC50 for glutamate displacement is 0.09 mm (Fig. 1) . The relative order of potencies shown in Fig.1 differs considerably from that observed by Syvertsen & Fonnum (1989) . This could be due to the freezing of membranes before assay by these workers, a process reported to decrease glutamate binding to membranes (Sharif & Roberts, 1984; Filbin et al., 1985) . Alternatively, performing the binding assay at 4°C and in the presence of Cl -may also contribute to the observed differences.
In our hands, freezing the Nephrops muscle membranes and subsequently assaying at 4°C in Tris/HCl, as described by Syvertsen & Fonnum (1989) , abolished quisqualate-sensitivity. However, we were unable to detect an increase in sensitivity to ibotenate (results not shown). We did, however, observe considerable variation in the quisqualate-sensitivity of glutamate binding under our assay conditions (the IC50 values ranged between 1 and 100 /uM). We have been unable to determine the reason for the variation, although the complex displacement curves shown in Fig. I imply that (Shinozaki, 1988; Syvertsen & Fonnum, 1989) Purification of the solubilized glutamate-binding sites achieved with concanavalin A was due to the small number of membrane proteins retained by, and specifically eluted from, the column (Fig. 4) . A similarly small number of concanavalin A-positive proteins were found by Breer & Knipper (1985) in insect synaptic membranes. A substantial proportion (approx. 60 %) of the glutamate-binding sites were not retained by the concanavalin column. These quisqualate-and kainate-insensitive sites may correspond to the lower-affinity sites detected in the membranes.
Subsequent gel filtration resulted in the identification of three sizes of glutamate-binding site. The middle peak appeared to be the product(s) of proteolysis, since it increased in the absence of the wide range of protease inhibitors used in this preparation. The polypeptide composition (Fig. 4) would be consistent with such a proposition. The high-Mr peak has a Stokes radius of 5.4 nm and an approximate Mr of 300000, with a subunit Mrof 74000. The subunit Mr is similar to the radiation-inactivation measurement of the glutamate-binding site in cockroach and mammalian synaptic membranes (Bardsley & Roberts, 1985; Sepulveda & Sattelle, 1989) , but not with the AMPA-binding site (Mr 43200; Honore & Nielsen, 1985) . The third peak, containing a polypeptide of Mr 65000, ran anomalously on the gel-filtration column, in a manner similar to that described for two polypeptides (Mr 71000 and 63000) which are thought to be part of a rat glutamate receptor (Chen et al., 1988) . The presumptive interaction with the AcA34 matrix was fortuitous in that it has permitted the separation of this protein, which showed no quisqualate-sensitivity, from the Mr-74000 protein, which was quisqualate-sensitive.
The result of the Scatchard analysis of glutamate binding to the Mr-74000 protein (i.e. 4.6 mol of glutamate to I mol of protein) suggested that the intact protein may consist of four similar subunits of Mr 74000, each of which binds to glutamate. Such a homotetrameric structure for a neurotransmitter receptor has been suggested for the locust acetylcholine receptor . However, further analysis will be required to prove such a structure, since some aggregation may have occurred in the low concentrations of detergent used, the estimate of the Mr is inaccurate, and the ratio obtained (4.6: 1) is not very convincing. We were unable to detect any co-operativity in the glutamate binding to either protein, even though biophysical experiments have suggested that there is co-operativity in channel gating of the excitatory receptor in both the locust muscle (Kerry etal., 1988) and at the crayfish neuromuscular junction (Dudel, 1977) . It is therefore conceivable that this protein is not involved in excitatory responses to glutamate, but rather in inhibitory responses, since chloride-and quisqualate-sensitive binding proteins have recently been described (Brose etal., 1989) .
In summary, we have isolated a protein with a subunit Mr of 74000, which may consist of four polypeptides each having a quisqualate-sensitive glutamate-binding site. The data suggest that this protein is a crustacean muscle glutamate receptor. The relationship, if any, between this protein and the Mr-65000 protein is unknown. It is conceivable that the latter is a breakdown product which has lost its quisqualate-sensitivity as a result of proteolysis.
We are grateful to Dr. 1. Duce and Dr. R. McKernan for much help and advice. F.R.B. is the recipient of an M.R.C. Training Award. This work was funded by a grant from the S.E.R.C.
